Skip to main content
OpenTrials
Completed

NCT Number: NCT00373282

Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy

To evaluate the effect of triamcinolone acetonide in silicone-filled eyes on the outcome of surgery for PVR.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Proliferative Vitreoretinopathy Eye Diseases Retinal Detachment Retinal Diseases Vitreoretinopathy, Proliferative

Age range

0 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Hamid Ahmadieh,MD

Tehran, Tehran Province, 16666, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cases of rhegmatogenous retinal detachment complicated by PVR grade C undergoing vitrectomy and silicone oil tamponade.

Exclusion criteria

  • History of trauma
  • Presence of diabetic retinopathy
  • History of vein occlusion
  • Giant retinal tear

Treatment and study plan

Triamcinolone Acetonide

Drug

Primary outcomes

  1. Single-operation retinal reattachment rate six

  2. months after surgery.

Secondary outcomes

  1. Visual acuity

  2. Retinal reproliferation

  3. Intraocular pressure

  4. Early silicone oil emulsification

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Important dates

Study start
2001
Study completion
2003
First posted
Sep 8, 2006
Registry last updated
Oct 12, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.